GSK achieves excellent performance across Vaccines, Specialty and General Medicine
GSK achieves excellent performance across Vaccines, Specialty and General Medicine
Stay updated with breaking news from Adjusted Operating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GSK achieves excellent performance across Vaccines, Specialty and General Medicine
/PRNewswire/ -- RPC, Inc. (NYSE: RES) today announced its unaudited results for the first quarter ended March 31, 2023. RPC provides a broad range of...
/PRNewswire/ -- Spirit Airlines, Inc. ("Spirit" or the "Company") (NYSE: SAVE) today reported first quarter 2023 financial results. First Quarter 2023...
MIRAMAR, Fla., April 26, 2023 /PRNewswire/ -- Spirit Airlines, Inc. today reported first quarter 2023 financial results. ... | June 18, 2023
Net income of $0.72 per diluted share. Net income per diluted share more than doubled from Q1 2022. Revenue of $5.7 billion, increased 33% year-over-year. Operating margin of 17.2%,... | April 25, 2023